18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features

This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed...

Full description

Bibliographic Details
Main Authors: Xiang Zhou, Alexander Dierks, Olivia Kertels, Malte Kircher, Andreas Schirbel, Samuel Samnick, Andreas K. Buck, Sebastian Knorz, David Böckle, Lukas Scheller, Janin Messerschmidt, Mohammad Barakat, K. Martin Kortüm, Leo Rasche, Hermann Einsele, Constantin Lapa
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/8/2333
id doaj-8b43eea444ea4405ac81e5df5f899cdc
record_format Article
spelling doaj-8b43eea444ea4405ac81e5df5f899cdc2020-11-25T03:24:06ZengMDPI AGCancers2072-66942020-08-01122333233310.3390/cancers1208233318F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical FeaturesXiang Zhou0Alexander Dierks1Olivia Kertels2Malte Kircher3Andreas Schirbel4Samuel Samnick5Andreas K. Buck6Sebastian Knorz7David Böckle8Lukas Scheller9Janin Messerschmidt10Mohammad Barakat11K. Martin Kortüm12Leo Rasche13Hermann Einsele14Constantin Lapa15Department of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Diagnostic and Interventional Radiology, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Internal Medicine II, University Hospital of Würzburg, 97080 Würzburg, GermanyDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, GermanyThis study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed clinical characteristics and PET imaging data of 10 patients with SMM. We found a significant correlation between bone marrow (BM) plasma cell (PC) infiltration and mean standardized uptake values (SUV<sub>mean</sub>) of lumbar vertebrae L2-L4 on 11C-Methionine PET/CT scans (<i>r</i> = 0.676, <i>p</i> = 0.031) and 68Ga-Pentixafor PET/CT scans (<i>r</i> = 0.839, <i>p</i> = 0.002). However, there was no significant correlation between BM involvement and SUV<sub>mean</sub> of lumbar vertebrae L2-L4 on 18F-FDG PET/CT scans (<i>r</i> = 0.558, <i>p</i> = 0.093). Similarly, mean target-to-background ratios (TBR<sub>mean</sub>) of lumbar vertebrae L2-L4 also correlated with bone marrow plasma cell (BMPC) infiltration in 11C-Methionine PET/CT (<i>r</i> = 0.789, <i>p</i> = 0.007) and 68Ga-Pentixafor PET/CT (<i>r</i> = 0.724, <i>p</i> = 0.018) PET/CT. In contrast, we did not observe a significant correlation between BMPC infiltration rate and TBR<sub>mean</sub> in 18F-FDG PET/CT (<i>r</i> = 0.355, <i>p</i> = 0.313). Additionally, on 11C-Methionine PET/CT scans, we found a significant correlation between BMPC infiltration and TBR<sub>max</sub> of lumbar vertebrae L2-L4 (<i>r</i> = 0.642, <i>p</i> = 0.045). In conclusion, 11C-Methionine and 68Ga-Pentixafor PET/CT demonstrate higher sensitivity than 18F-FDG PET/CT in detecting BM involvement in SMM.https://www.mdpi.com/2072-6694/12/8/233318F-FDG PET/CT11C-Methionine PET/CT68Ga-Pentixafor PET/CTsmoldering myeloma
collection DOAJ
language English
format Article
sources DOAJ
author Xiang Zhou
Alexander Dierks
Olivia Kertels
Malte Kircher
Andreas Schirbel
Samuel Samnick
Andreas K. Buck
Sebastian Knorz
David Böckle
Lukas Scheller
Janin Messerschmidt
Mohammad Barakat
K. Martin Kortüm
Leo Rasche
Hermann Einsele
Constantin Lapa
spellingShingle Xiang Zhou
Alexander Dierks
Olivia Kertels
Malte Kircher
Andreas Schirbel
Samuel Samnick
Andreas K. Buck
Sebastian Knorz
David Böckle
Lukas Scheller
Janin Messerschmidt
Mohammad Barakat
K. Martin Kortüm
Leo Rasche
Hermann Einsele
Constantin Lapa
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
Cancers
18F-FDG PET/CT
11C-Methionine PET/CT
68Ga-Pentixafor PET/CT
smoldering myeloma
author_facet Xiang Zhou
Alexander Dierks
Olivia Kertels
Malte Kircher
Andreas Schirbel
Samuel Samnick
Andreas K. Buck
Sebastian Knorz
David Böckle
Lukas Scheller
Janin Messerschmidt
Mohammad Barakat
K. Martin Kortüm
Leo Rasche
Hermann Einsele
Constantin Lapa
author_sort Xiang Zhou
title 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title_short 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title_full 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title_fullStr 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title_full_unstemmed 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
title_sort 18f-fdg, 11c-methionine, and 68ga-pentixafor pet/ct in patients with smoldering multiple myeloma: imaging pattern and clinical features
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2020-08-01
description This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed clinical characteristics and PET imaging data of 10 patients with SMM. We found a significant correlation between bone marrow (BM) plasma cell (PC) infiltration and mean standardized uptake values (SUV<sub>mean</sub>) of lumbar vertebrae L2-L4 on 11C-Methionine PET/CT scans (<i>r</i> = 0.676, <i>p</i> = 0.031) and 68Ga-Pentixafor PET/CT scans (<i>r</i> = 0.839, <i>p</i> = 0.002). However, there was no significant correlation between BM involvement and SUV<sub>mean</sub> of lumbar vertebrae L2-L4 on 18F-FDG PET/CT scans (<i>r</i> = 0.558, <i>p</i> = 0.093). Similarly, mean target-to-background ratios (TBR<sub>mean</sub>) of lumbar vertebrae L2-L4 also correlated with bone marrow plasma cell (BMPC) infiltration in 11C-Methionine PET/CT (<i>r</i> = 0.789, <i>p</i> = 0.007) and 68Ga-Pentixafor PET/CT (<i>r</i> = 0.724, <i>p</i> = 0.018) PET/CT. In contrast, we did not observe a significant correlation between BMPC infiltration rate and TBR<sub>mean</sub> in 18F-FDG PET/CT (<i>r</i> = 0.355, <i>p</i> = 0.313). Additionally, on 11C-Methionine PET/CT scans, we found a significant correlation between BMPC infiltration and TBR<sub>max</sub> of lumbar vertebrae L2-L4 (<i>r</i> = 0.642, <i>p</i> = 0.045). In conclusion, 11C-Methionine and 68Ga-Pentixafor PET/CT demonstrate higher sensitivity than 18F-FDG PET/CT in detecting BM involvement in SMM.
topic 18F-FDG PET/CT
11C-Methionine PET/CT
68Ga-Pentixafor PET/CT
smoldering myeloma
url https://www.mdpi.com/2072-6694/12/8/2333
work_keys_str_mv AT xiangzhou 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT alexanderdierks 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT oliviakertels 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT maltekircher 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT andreasschirbel 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT samuelsamnick 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT andreaskbuck 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT sebastianknorz 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT davidbockle 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT lukasscheller 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT janinmesserschmidt 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT mohammadbarakat 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT kmartinkortum 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT leorasche 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT hermanneinsele 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
AT constantinlapa 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures
_version_ 1724603380578385920